1 Min Read
(Reuters) - AbbVie Inc said on Wednesday it expects first-quarter earnings to be hit by acquired in-process research and development (IPR&D) and milestones expenses.
The company expects first-quarter adjusted earnings, including the impact of acquired IPR&D and milestones expense, to be between $2.31 per share and $2.41 per share.
Reporting by Arunima Kumar in Bengaluru; Editing by Sriraj Kalluvila
China receives US equipment to make advanced chips despite new rules - report
China receives US equipment to make advanced chips despite new rules-report
U.S. Treasury yields have peaked, say strategists for fourth straight month: Reuters poll
Google's expert in US antitrust trial defends billions paid to device makers
Post-strike Hollywood rushes to get film, TV sets humming
